Case Report : Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma

Hepatoid adenocarcinoma (HAC) is a rare type of extrahepatic carcinoma whose morphology is similar to that of hepatocellular carcinoma (Hcc).Metachronous HCC and HAC in the Same patient is extremely rare. The case of a 68-yearold man with chronic hepatitis B infection who had both Hcc and HAC of the...

Full description

Saved in:
Bibliographic Details
Published inClinical and molecular hepatology Vol. 19; no. 2; pp. 173 - 178
Main Authors Joon Seong Ahn, Ja Ryong Jeon, Hong Seok Yoo, Taek Kyu Park, Cheol Keun Park, Dong Hyun Sinn, Seung Woon Park
Format Journal Article
LanguageKorean
Published 대한간학회 25.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hepatoid adenocarcinoma (HAC) is a rare type of extrahepatic carcinoma whose morphology is similar to that of hepatocellular carcinoma (Hcc).Metachronous HCC and HAC in the Same patient is extremely rare. The case of a 68-yearold man with chronic hepatitis B infection who had both Hcc and HAC of the stomach is reported herein. Nine years previously this patient had been diagnosed with HCC received a right lobectomy. HCC that recurred at the caudate lobe at 6 months after the operation was successfully treated with transarterial chemoembolization. The patient was followed up regularly thereafter without evidence of tumor recurrence for 9 years. In July 2010 his serum alpha-fetoprotein (AFP) level elevated from 6.5 ng/mL, and he developed a probable single metastatic Iymph node around the hepatic artery without intrahepatic lisions. Subsequent evaluation with upper endoscopy revealed a 4-cm ulcerative lesion on the antrum of the stomach. Subtotal gastrectomy was performed with Iymph-node dissection. Histologic examination revealed a special type of extrahepatic AFP-producing adenocarcinoma-HAC with Iymph-node metastasis-which indicates that HAC can be a cause of elevated AFP even in patients with HCC. HAC should be considered if a patient with stable HCC exhibits unusual elevation of AFP.
Bibliography:The Korean Association for the Study of the Liver
ISSN:2287-2728
2287-285X